Clinical Trials Browser

Interventional × Prostatic Neoplasms × pazopanib × Clear all

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT01385228 2018-06-06

Pazopanib, Docetaxel, Prednisone Prostate

Phase 1 Completed

36 enrolled

Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

NCT00486642 2017-05-24

Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Phase 2 Completed

23 enrolled 14 charts

Genitourinary

Prostatic Neoplasms

NCT00454571 2016-02-10

Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer

Phase 2 Completed

37 enrolled 5 charts

Genitourinary

Prostatic Neoplasms

NCT00945477 2013-11-18

Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockade

Phase 2 Terminated

11 enrolled 6 charts

Genitourinary

Prostatic Neoplasms

Clinical Trials

IVY

Pazopanib, Docetaxel, Prednisone Prostate

Pazopanib Hydrochloride With or Without Bicalutamide in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Pazopanib Hydrochloride After Leuprolide Acetate or Goserelin Acetate in Treating Patients With Relapsed Prostate Cancer

Pazopanib as Second Line Therapy in Patients With Metastatic Prostate Cancer Refractory to Total Androgen Blockade